| Literature DB >> 20096131 |
Beena Bhandari1, Pankaj Bansal, Pankaj Talwar, Satish K Gupta.
Abstract
BACKGROUND: Human egg is enveloped by a glycoproteinaceous matrix, zona pellucida (ZP), responsible for binding of the human spermatozoa to the egg and induction of acrosomal exocytosis in the spermatozoon bound to ZP. In the present manuscript, attempts have been made to delineate the downstream signalling components employed by human ZP to induce acrosome reaction.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20096131 PMCID: PMC2832785 DOI: 10.1186/1477-7827-8-7
Source DB: PubMed Journal: Reprod Biol Endocrinol ISSN: 1477-7827 Impact factor: 5.211
Human SIZP mediated induction of acrosome reaction in capacitated human sperm
| Treatment | Percent induction of acrosomal exocytosis (Mean ± SEM) | Statistical significance |
|---|---|---|
| PBS Control | 13.7 ± 1.4 | |
| SIZP (~1 zona) | 26.3 ± 1.4 | p = 0.003c |
| SIZP (~2 zonae) | 29.4 ± 0.4 | p = 0.009c |
| SIZP (~5 zonae) | 39.7 ± 1.7 | p = 0.0003c |
| SIZP (~10 zonae) | 36.4 ± 0.9 | p = 0.0009c |
| PBS control | 14.7 ± 1.3 | |
| PBS + SIZP (~5 zonae) | 36.1 ± 3.1 | p = 0.007c |
| Calcium ionophore (10 μM) | 56.1 ± 4.5 | p = 0.0001c |
aSIZP mediated acrosome reaction was studied by employing semen samples from three different donors
bSIZP mediated acrosome reaction was studied by employing semen samples from six different donors
cValues are statistically significant as compared to respective PBS control
Figure 1SIZP mediated intracellular calcium release profile in capacitated human sperm in presence or absence of pharmacological inhibitors of L- and T-type VOCCs. Fluo-3/AM labelled capacitated human sperm (1 × 106) were pre-incubated with either L- type VOCC inhibitor, Verapamil (10 μM) or T-type VOCC inhibitor, pimozide (20 μM), for 10 minutes and then exposed to SIZP (~5 zonae) at 0 seconds. Changes in intracellular calcium levels (nM; y-axis) have been plotted as a function of time (seconds; x-axis) for ~10 min. Blue line represents SIZP mediated calcium increase profile whereas pink and green lines represent SIZP mediated calcium release profile after prior treatment of labelled sperm with Pimozide and Verapamil respectively. Values are presented as Δ [Ca2+]i obtained by subtracting the respective mean resting [Ca2+]i values preceding SIZP addition from the peak [Ca2+]i.
Figure 2SIZP mediated induction of acrosome reaction in capacitated human sperm in presence or absence of pharmacological inhibitors of L- and T-type VOCCs. Capacitated human sperm (1 × 106) pre-incubated for 10 min at 37°C in presence of 5% CO2, with L-type VOCC inhibitors (Nifedipine, Verapamil), T-type VOCC inhibitors (Pimozide, Mibefradil) or respective vehicle controls (Panels 2a and 2b respectively) were subsequently incubated with SIZP (~5 zonae). After 60 min incubation at 37°C in presence of 5% CO2, sperm samples were analyzed for their acrosomal status by TRITC-PSA staining as described in Methods. Y-axis represents percent induction of acrosomal exocytosis calculated by dividing the number of acrosome-reacted sperm by total number of sperm counted and multiplied by 100. Values are Mean ± SEM of six different experiments using semen samples from at least six different male donors. Calcium ionophore A23187 (10 μM) was used as a positive control in the experiment. Asterisk (*) represents p < 0.05 with respect to the solvent control and hash (#), p < 0.05 with respect to SIZP mediated induction of acrosome reaction.
Human SIZP mediated induction of acrosome reaction in capacitated human sperm in presence or absence of various pharmacological inhibitors.
| Treatment | Percent induction of acrosomal exocytosis (Mean ± SEM) | Statistical significance |
|---|---|---|
| PBS control | 14.5 ± 0.5 | |
| PBS + SIZP | 31.1 ± 1.2 | p = 0.04*b |
| EGTA (8 mM) + SIZP | 16.2 ± 0.9 | p = 0.001*c |
| Pertussis toxin (0.1 μg/ml) + SIZP | 21.1 ± 0.8 | p = 0.02*c |
| H-89 (20 μM) + SIZP | 19.8 ± 0.9 | p = 0.02*c |
| Alcohol control | 14.5 ± 0.7 | |
| Alcohol + SIZP | 28.9 ± 1.0 | p = 0.0004*b |
| Picrotoxin (50 μM) + SIZP | 23.4 ± 0.5 | p = 0.005*c |
| Picrotoxin (100 μM) + SIZP | 21.3 ± 0.5 | p = 0.0007*c |
| DMSO Control | 15.7 ± 1.4 | |
| DMSO + SIZP | 36.0 ± 1.4 | p = 0.0001*b |
| Chelerythrine chloride (2 μM) + SIZP | 21.5 ± 1.4 | p = 0.006*c |
| Chelerythrine chloride (3 μM) + SIZP | 21.2 ± 2.4 | p = 0.007*c |
| Wortmannin A (50 nM) + SIZP | 22.3 ± 0.6 | p = 0.0001*c |
| Wortmannin A (100 nM) + SIZP | 25.0 ± 1.7 | p = 0.008*c |
| Herbimycin A (10 μM) + SIZP | 21.0 ± 1.2 | p = 0.012*c |
| Herbimycin A (15 μM) + SIZP | 19.1 ± 0.9 | p = 0.02*c |
aCapacitated human sperm (1 × 106) pre-treated with or without respective inhibitor were incubated with SIZP (5 zonae) for 60 min
bValues are statistically significant as compared to PBS control
cValues are statistically significant as compared to SIZP